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ABSTRACT 
Background: Cardiovascular disease (CVD) causes 45% of firefighters’ on-duty deaths, but the 
risk of these events is limited to susceptible individuals. Left ventricular hypertrophy 
(LVH)/cardiomegaly increases arrhythmia, myocardial infarction, stroke and death risks, and is a 
condition which renders firefighters susceptible to CVD events. Autopsies demonstrate 
LVH/cardiomegaly in most firefighter CVD fatalities. If recognized beforehand, however, 
effective treatments are available. In this work we i) describe the state of the art knowledge on 
the definition of cardiac enlargement across imaging modalities, normalization techniques 
(indices) and reference ranges; ii) estimate the current prevalence of cardiac enlargement among 
the US firefighters; and iii) identify the significant predictors of LV mass (LVM).
Methods: We conducted a literature review to compare measurements for heart size and mass by 
cardiac MRI (CMR), Echocardiograms (ECHO) and autopsies in healthy and diseased hearts in 
the general population (Chapter 1). We selected 400 participants by an enriched randomization 
sampling strategy from a population of active firefighters. All participants received a screening 
ECHO, followed by CMR. Prevalence estimates for LVH were derived among the active 
firefighters based on ECHO and CMR. Separate estimates were made by examining autopsies of 
other firefighters who suffered a noncardiac on-duty fatality (Chapter 2). Risk factors were 
evaluated as predictors for LVM normalized for height (Chapter 3). 
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Results: The findings from Chapter 1 demonstrated a wide variance in LVH definitions and 
reference ranges; ECHO remains the most widely used diagnostic tool; and few direct 
comparisons exist between imaging and autopsies studies at this time. Chapter 2 showed a wide 
range of prevalence estimates of cardiac enlargement and body mass index (BMI) to be a major 
driver of heart weight. Chapter 3 identified BMI as the most significant and only consistent 
independent predictor of LVM indices. 
 
Conclusions: Standardization of cardiac enlargement definitions is needed.  However, BMI 
drives LVM, heart weight and LV wall thickness. Therefore, reducing obesity will decrease the 
prevalence of LVH/cardiac enlargement in the fire service, which should in turn reduce CVD 
events. 
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Introduction !
Cardiovascular disease (CVD) is the leading cause of on-duty death among US firefighters and 
an important and costly cause of morbidity. CVD causes 45% of firefighters’ on-duty deaths. As 
in the general population, these cardiovascular events are largely due to coronary heart disease 
(CHD). 1-4 There is also an increasing recognition in the role of Left Ventricular Hypertrophy 
(LVH)/cardiomegaly in the risk of Sudden Cardiac Death (SCD) independent of the presence of 
CHD, although it has long been recognized that individuals dying of CHD tend to have heavier 
hearts than those dying of non-cardiac causes.5-7 
 For every fatal on-duty CVD event, there are an 
estimated 25 nonfatal, line-of-duty CVD events in the US fire service. 8,9!&'(!($)(*)!+,!)'"-!./+01(2!"*!)'(!3454!,"/(!-(/#"6(!'7-!*+)!6'7*8(9!-"8*","67*)1:!"*!)'(!17-)!);+!9(679(-<!9(-.")(!27=+/!79#7*6(-!"*!67/9"+#7-6>17/!2(9"6"*(4%!?<%@<%% In addition, firefighting combines situations that are 
both physically demanding (intense work, heavy tools & personal protective gear) and 
psychologically stressful (alarm response, danger) that together with environmental hazards (heat 
stress, noise, dehydration, particulate and gaseous exposures in smoke) can easily trigger a CVD 
event in a susceptible individual. 1,12  
LVH/cardiomegaly is considered a structural abnormality of the heart13,14 and appears to be a key 
pen-ultimate and predisposing step on the causal pathway that makes a firefighter susceptible to 
CVD events1,15,16. LVH/cardiomegaly has been widely recognized to increase the risk of lethal 
ventricular arrhythmias, myocardial infarction and stroke; and it is a proven predictor of CVD 
and overall mortality in the general population but have not been adequately researched in the 
fire service.17-21  Current evidence from autopsy-based case series of SCD indicates that LVH is 
common among US firefighters, often co-morbid with CHD and plays a major role in CVD 
! A!
events and SCD risk in the fire service. In fact, the majority of CVD death victims suffered from 
LVH/cardiomegaly, which was usually unrecognized before death. 22,23  
 
Beyond its role in CVD and the fact that it is likely common, in order to justify screening for 
LVH/cardiomegaly, we also need to recognize that it can be treated and reversed at an early 
stage. The detection of LVH by imaging should rarely, if ever, be a career-ending event for a 
firefighter.  In fact, there are several proven effective treatments for LVH based on its underlying 
risk factors. In the presence of hypertension, anti-hypertensive drugs and particularly, 
angiotensin converting enzyme (ACE) inhibitors can produce echocardiographically-confirmed 
regression of LVH.21 Furthermore, in patients with Obstructive Sleep Apnea (OSA), continuous 
positive airway pressure (CPAP) can produce reductions in LVH.24 Finally, weight loss through 
both diet and exercise in overweight and obese subjects is beneficial because it can improve 
OSA, blood pressure control and can reverse obesity-related effects on LV mass (LVM).25 
 
Despite the critical prognostic significance of LVH/cardiomegaly for CVD and SCD events, its 
definition demonstrates wide variability among measurement techniques, imaging modalities, 
normalization processes, technicians and institutions. 26,27   Evidence suggests an increasing 
prognostic value, when LVH is based on the accurate assessment of LVM, with LVM being an 
independent predictor for cardiovascular risk. 26,28 However, the role of LVM in clinical practice 
and desicion-making has not been firmly established due to a number of controversies that 
surround its assessment28,29. LVM values present a wide distribution among healthy individuals, 
with distinct differences observed by sex and ethnicity,creating the need to account for body size 
in order to be able to make reasonable inferences. Indexing LVM, using different methods with 
! B!
different body size parameters, such as height, weight, body mass index or body surface area, has 
been the most common normalization process to date. However, there is no agreed upon 
consensus regarding cut-off values on LVM indices, creating further challenges in the definition 
of LVH.27,29-31   
 
Echocardiography (ECHO) and cardiac magnetic resonance (CMR), the two most frequently 
used imaging modalities for LVM assessment, use different algorithms and measurement 
techniques, providing different average values along with different degrees of accuracy. 26,27 In 
addition, LVM can also be physiologically increased by healthy behaviors such as endurance 
physical training, an observation that should be accounted for while establsihing LVM reference 
values.28,32,33   
 
There is no consensus on the measurement of LVM, the calculation of LVM indexing, the 
classification of LVH/cardiomegaly based on firm cut-off values. To date most studies in 
firefighters have relied on autopsy data. Forensic studies, however, rarely assess LVM, and 
instead, they measure routinely total cardiac mass as an indicator of potential cardiomegaly, 
creating challenges on direct comparisons between the mass of the left ventricle and the total 
cardiac mass, in order to establish a firm relationship between the two. 
 
By combining the use of CMR with ECHO along with other comprehensive clinical data, we can 
most accurately estimate the prevalence of LVH/cardiomegaly in career firefighters. Moreover, 
by identifying the significant predictors of LVM there will be a tremendous effect in clinical 
practice and therapeutic decision-making, allowing for identification of LVH/cardiomegaly in a 
! ?!
timely fashion, thus enabling clinical interventions to decrease firefighters’ morbidity and 
mortality.  
 
Dissertation Goal 
The specific aims of this dissertation are: 1) to conduct a systematic literature review so as to 
describe heart size and mass ranges in normal and diseased hearts in the general population, with 
specific goals: i) to compare measurements for heart size and mass by CMR, ECHO, and 
autopsies in healthy and diseased hearts; and ii) to assess the relationship between LVM and total 
heart weight (see Chapter 1); 2) to estimate the prevalence of cardiac enlargement (including 
LVH) in active career US Firefighters and present how the prevalence estimates vary according 
to the method of assessment; by autopsies, ECHO and CMR (see Chapter 2); and 3) to identify 
the most important predictors of LVM in male firefighters in the United States that could further 
contribute to more accurate medical screening and wellness programs for firefighters (see 
Chapter 3) . 
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Abstract   !
Left ventricular hypertrophy (LVH) is widely recognized as an independent and significant 
predictor of cardiovascular disease (CVD) and sudden cardiac death (SCD) risk. It is also 
assumed that the predictive value of LVH is increased by its accurate assessment based on LV 
mass (LVM). However, LVH definition along with LVM reference values, demonstrate wide 
variability among imaging modalities, technicians, indexing methods and institutions. In 
addition, currently autopsy studies measure total heart weight rather than LVM, which makes 
them difficult to correlate with imaging data. Therefore, we conducted a systematic literature 
review for existing data on methods used and reference values for both normal and diseased 
hearts. Echocardiography remains the most widely used diagnostic tool for the evaluation of 
LVH, with the optimal body-size indexing formula remaining controversial and in urgent need of 
more standardization. Future forensic studies are needed to directly compare total cardiac mass 
to left ventricular mass and in order to update reference values considering significant changes in 
the population’s height and weight.  
 
Keywords: heart weight, left ventricle, hypertrophy, autopsies, echocardiography, cardiac 
magnetic resonance 
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Background !
Cardiomegaly is a general term used to describe increased heart size whereas left ventricular 
hypertrophy (LVH) describes both increased wall thickness and mass, due to a thickening of the heart 
muscle surrounding the left ventricle. Both cardiomegaly and LVH are considered structural 
abnormalities of the heart. 1,2 Cardiomegaly and LVH are strongly associated with cardiovascular 
morbidity and mortality,1,3-5 all cause mortality,6,7 and, in particular, sudden cardiac death 
(SCD).8Cardiomegaly/LVH are known to increase the risk of lethal ventricular arrhythmias, 
myocardial infarction, and stroke.3,9-12 For example, the risk of SCD is approximately six times 
greater for men with electrocardiographically detected LVH than men without LVH.13 Although 
it has long been recognized that individuals dying of Coronary Heart Disease (CHD) tend to 
have heavier hearts than those dying of non-cardiac causes, 14 the prevalence and relevance of 
cardiomegaly/LVH have received far less attention than has the presence of coronary 
atherosclerosis and stenosis. Significantly, a recent study that retrospectively studied the cardiac 
findings of adults who died of SCD and attributed the deaths to cardiomegaly/LVH, CHD, or 
both found that cardiomegaly/LVH is a frequent cause of SCD in the general public and is highly 
associated with obesity and death at a younger age than CHD.15 Hypertensive individuals with 
LVH present a 2-to 5-fold increase in fatal and non-fatal cardiovascular events when compared 
to those with hypertension alone;16 hence, LVH is currently recognized as target-organ damage 
that influences prognosis in hypertensive populations.17-19  
There is a consensus that the presence of LVH is best determined by estimating the Left 
Ventricular mass (LVM). The accurate evaluation of LVM is fundamental, not only for the 
determination of the degree of hypertrophy but also for the assessment of its regression.20-22 Over 
the last two decades, along with the recognition of the critical prognostic value of LVM in 
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cardiovascular risk algorithms, 10,23 substantial progress has been made in educating both 
clinicians and epidemiologists on the role of LVM.,24 However, despite this increasing 
recognition of the importance of LVM, the best way to incorporate it’s measurement into clinical 
practice has not been firmly established  due to a number of controversies that surround its 
quantitative assessment.23,25,26  
LVM values present a wide distribution among healthy individuals, with distinct differences 
observed by sex and ethnicity, as well as the frequency of athletic training. Hence, 
anthropometric parameters should be taken into account to make meaningful comparisons among 
individuals. Indexing LVM, using different methods with regards to height, weight, body mass 
index or body surface area, has been the most common normalization process to date. The LVM 
indexing method has a critical role in the definition of LVH and its performance as a 
cardiovascular risk predictor.17,18,23,25,27-29 And yet, there is currently no agreed upon convention 
for normalizing LVM.  This lack of consensus on normalization complicates efforts to identify 
the most appropriate cut-off values for defining LVH or initiating treatment. 
Not only is there inconsistency in the normalization of LVH values, there are also different 
modalities for assessing LVM.  The two most frequently used imaging modalities for the 
assessment of LVM, and thus non-invasive identification of LVH, have been echocardiography 
(ECHO) and cardiac magnetic resonance (CMR).30 ECHO and CMR rely on different 
technologies and use different algorithms for the assessment of LVM, providing different 
average values along with different degrees of accuracy.23,31,32 The differences between these 
methods can make the distinctions between disease states and normality harder to make.33  
Heart weight is routinely assessed during autopsies.  Such information holds promise to better 
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describe the normal distribution of heart size and mass as well as to improve the understanding 
of cardiac pathology.  The accurate assessment of the heart weight at autopsies and the ability to 
conduct comparisons with updated reference values are key considerations in determining the 
presence of structural heart disease among deceased individuals.34 However, directly comparing 
heart weight at autopsy with clinical data during life is hampered by different assessment 
techniques and a lack of comparative data.  So far, limited information exists, thus not allowing 
direct comparisons between heart mass in autopsies and clinical imaging. Imaging modalities 
focus on the determination of cardiomegaly/LVH via LVM assessment, while autopsies focus on 
total cardiac mass and left ventricular wall thickness for establishing cardiomegaly/LVH. In 
addition, little is known regarding the relationship of LVM to the total cardiac mass, a feature 
that could facilitate extrapolations or comparisons between imaging modalities and autopsies. 
The main aim of this review is to describe heart size and mass ranges in normal and diseased 
hearts in the general population. The specific goals are: 1) to compare measurements for heart 
size and mass by CMR, ECHO, and autopsies in healthy and diseased hearts; and 2) to assess the 
relationship between LVM and total cardiac mass.  
LVM in healthy & diseased hearts !
LVM has been shown to be a strong predictor of cardiovascular events among individuals 
without3,35,36 and with prior coronary heart disease37,38 and those with heart failure1,39. An increase 
in LVM is associated with a higher incidence of cardiovascular events, including death, while a 
decrease is a marker of lower risk for cardiovascular events, especially among patients on anti-
hypertensive treatment.20,22 Therefore, the correct assessment of LVM using non-controversial 
reference ranges is vital to accurately determine prognosis. 23 
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 The evaluation of LVM can be performed by a number of imaging modalities, with the ECHO 
and the CMR being the most studied so far.40 For both techniques, scientific societies have 
developed guidelines regarding technical procedures, validation, and clinical indications.31,32,41 
However, these guidelines are not standardized, allowing for a great variation in the 
measurement of LVM and thus the classification of LVH, which can differ from study to study, 
from institution to institution, and from laboratory to laboratory. The primary method of LVM 
determination is based on calculating the shell volume which is obtained as the difference of 
epicardial and endocardial volumes. The shell volume is subsequently converted to mass by 
multiplying it by the specific density of myocardial tissue, which is usually assumed to be 
1.05g/ml.31,42 
Electrocardiography (EKG), though widely used, lacks sufficient sensitivity as an LVH 
screening tool and does not provide anatomic measurements of size or weight.12 Moreover, 
because EKG LVH criteria rely on voltage,43,44 the EKG is even less sensitive in obese 
individuals due to the attenuation of voltage signals by increased distance and tissues between 
the heart and the EKG leads.45 
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Assessment of LVM by imaging modalities !
Assessment of LVM by ECHO !
Motion-mode (M-mode), 2-dimensional (2D) echocardiography and 3-dimensional (3D) 
echocardiography are the cornerstones of LVM echocardiographic assessment in modern 
cardiology practice and research.42 M-mode was the first non-invasive imaging technique 
developed in 1950s, at that time producing only one-dimensional information.46  
Its use is reasonable for normally shaped ventricles, as well as for abnormally shaped ventricles 
if real time images are used.
31,42
    Currently, 2D guided M-mode and 2D ECHO can be used 
routinely in each echocardiographic examination and remain the recommended method for the 
assessment of  LVM and thus  the determination of LVH.31,41,47 In the future, 3D ECHO, will be 
the next step in the LVM evaluation, but it is still currently experimental.42  
The echocardiographic determination of LVM has several limitations that need to be understood 
and sufficiently addressed to enable informed clinical decision-making and for interpreting and 
generalizing the corresponding findings. First, the need to calculate myocardial volume by 
cubing linear dimensions based on geometric assumptions limits the accuracy and reproducibility 
of this method.48-51 Moreover, due to the use of cubing values, the LVM algorithm may magnify 
measurement errors. In addition, ECHO measurements are dependent on the ability to obtain an 
adequate acoustic window and this may be complicated by body habitus, respiratory conditions, 
etc.  The technical adequacy of ECHO measurements is also dependent on operator skill and 
experience.31 
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The most recent reference values for ECHO chamber quantification were developed jointly by 
the American Society of ECHO (ASE )and the European Association of ECHO (EAE) in 200531; 
revised recommendations  with unchanged reference ranges have recently been published.41,43 
These values were derived from a population of normal-weight, normotensive, and non-diabetic, 
White, African American, and American Indian adults without recognized cardiovascular 
disease. Table 1.1 presents the reference values of LVM for both men and women as suggested 
by these guidelines.31,41 It is crucial to note that the reference limits for LVM, as presented by 
Lang et al.,31,41,43 are lower than other limits that have been published in previous ECHO studies, 
but are identical to those based on cut-off values used in clinical trials.22,31,45,52,53 However, we 
should consider that reference ranges that are derived based on healthy individuals only, can 
result in low cut-off values that may not be clinically realistic when applied to the diverse “real 
world” heterogeneous population.31 Moreover, the Echocardiographic Normal Ranges Meta-
Analysis of the Left Heart (EchoNoRMAL) Collaboration derived ethnic-specific normative 
reference ranges for echocardiographic LVM, using population-based datasets of 
echocardiographic measurements from adults with no clinically evident cardiovascular disease or 
risk factors. The specifics of these ethnic-specific ranges is beyond the scope of the current 
paper, but are available elsewhere.54  
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Table 1.1: Reference limits of Left Ventricular Mass and geometry by Echocardiography and Definition 
of Left Ventricular Hypertrophy, according to the Left Ventricular Mass index (LVMi) Cutoff Value by 
both Echocardiography and CMR. 
 
 
ECHO 
Women Men 
Reference 
Ranges 
Abnormal Severely 
Abnormal 
Reference 
Ranges 
Abnormal Severely 
Abnormal 
M-Mode/Linear Method 
LVM (g) 67-162 163-210 !211 88-224 225-292 !293 
LVM/BSA, (g/m2) 43-95 96-121 !122 49-115 116-148 !149 
LVM/height, (g/m) 41-99 100-128 !129 52-126 127-162 !163 
LVM/height2.7 
(g/m2.7) 
18-44 45-58 !59 20-48 49-63 !64 
Relative wall 
thickness (cm) 
0.22-0.42 0.43-0.52 !0.53 0.24-0.42 0.43-0.51 !0.52 
Septal thickness 
(cm) 
0.6-0.9 1.0-1.5 !1.6 0.6-1.0 1.1-1.6 !1.7 
Posterior wall 
thickness (cm) 
0.6-0.9 1.0-1.5 !1.6 0.6-1.0 1.1-1.6 !1.7 
2D Method 
LVM (g) 66-150 151-182 !193 96-200 201-254 !255 
LVM/BSA, (g/m2) 44-88 89-112 !113 50-102 103-130 !131 
LVMi Cutoff Values 
                                                               
                                                                    Women                                                             Men 
ECHO BSA >95 (g/m2)31 >115 (g/m2 ) 31 
Height1.7 >60 (g/m1.7)27 >81 (g/m1.7)27 
Height2.7 >47 (g/m2.7)25 >50 (g/m2.7)25 
CMR BSA >84.6 (g/m2)55 >106.2 (g/m2)55 
Height1.7 >60 (g/m1.7)27 >80 (g/m1.7)27 
Height2.7 >38 (g/m2.)55 >45.1 (g/m2.7)55 
CMR, cardiac magnetic resonance; ECHO, echocardiography; BSA, body surface area; LVM, left ventricular mass; 
LV, left ventricular; 2D, 2-dimensional LVMi, left ventricular mass index. 
 
Table adapted from Armstrong et al. 30 and Lang et al. 31 
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Assessment of LVM by CMR !
LVM determination by CMR allows for a 3D high-resolution modeling of the left ventricle.  It 
offers the advantages of being free of cardiac geometric assumptions, contrast infusion, acoustic 
window dependency, or ionizing radiation.42 In CMR, LVM is derived again as the product of 
the myocardial volume and the density of the myocardium.  Assessment of myocardial volume is 
done at end-diastole by convention. Nonetheless, measurement techniques still crucially 
influence LVM estimation.56-59 For instance, some controversy exists regarding the inclusion of 
papillary muscles in the calculation of the myocardial mass. The results from Multi-Ethnic Study 
of Atherosclerosis (MESA), which had the largest population for CMR assessment, show better 
reproducibility when the papillary muscles are excluded.60 However, Farber et al. in a more 
recent study of 58 explanted cardiomyopathy hearts suggests that the exclusion of papillary 
muscles should be reconsidered.61 Moreover, evidence suggests that CMR estimates of LVM 
show increased susceptibility to inter-observer segmentation variation among healthy subjects, 
which should be taken under consideration in the case of multi-center or longitudinal studies. 62  
Important limitations to the widespread clinical use of CMR include the high operational cost, 
the time to acquire and analyze the imaging (cine) data, the hazards associated with 
ferromagnetic metal devices, as well as issues related to claustrophobia in susceptible 
patients.30,40,59  
Although ECHO and CMR derived LVM estimates show high correlation, their absolute values 
differ, with CMR consistently yielding lower average values for the same subjects.49,50 The 
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difference between the estimates suggests that the two methods cannot be used interchangeably 
in the assessment of LVM. Farber et al. suggest that CMR, following the steady-state free 
precession process, is truly the gold standard for the non-invasive calculation of both the left and 
right ventricular mass, based on strong correlations between the imaging derived mass and the 
respective autopsy mass (r=0.99, p<0.001 and r=0.95, p<0.001 for total cardiac mass and LVM 
respectively) .61  
Despite the fact that CMR is considered the gold-standard for assessing LVM, ECHO is a well 
validated, non-invasive, and the widely used method in clinical practice.63 Table 1.2 presents the 
major comparative differences between the two modalities. 
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Table 1.2: Comparative Assessment between Echocardiographic and Cardiac Magnetic Resonance’s 
assessment of Left Ventricular Mass. 
 
 
 
Features/Attributes 
 
Best Performing Imaging Modality 
Non-Invasive Modality ECHO, CMR40 
Cost ECHO40 
Fast ECHO42 
Acceptability/Availability ECHO31,40,42 
Inter-Study Reproducibility 
(Relevant to normal, dilated & hypertrophic hearts) 
CMR11 
Acoustic Window Dependency CMR31,42 
Operator’s Experience Dependency CMR31 
Free of cardiac geometric Assumptions 
 
CMR40,64 
Accuracy & Precision  CMR40,63 
Lower Measurement Error CMR23 
Standardization of Measurements CMR23,31 
Hazards associated with metal devices ECHO40,59 
Claustrophobia ECHO40,59 
CMR, cardiac magnetic resonance; ECHO, echocardiography. 
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Assessment of LVM by indexing methods  !
LVM and heart size increase in proportion to the overall body size and thus differ by gender, 
with higher values seen in men.55,33 Anthropometric parameters should be considered to 
normalize myocardial mass, minimizing the effect of body size in the population distribution.30 
An LVM “index” is derived by dividing LVM with height, or by body surface area (BSA), or by 
comparing it to a reference group of healthy subjects. Due to the fact that relationships between 
body size and organ dimensions are often non-linear, allometric approaches are necessary, in 
which LVM is divided by a body size variable raised to a scalar exponent intended to describe 
the unique relationship between the variable and LVM.27,52,65 The normal range of the LVM 
index can subsequently be derived from a reference sample of individuals believed to be free of 
risk factors that could otherwise cause LV enlargement.55 It is also important to consider that in 
order to be clinically useful an indexed LVM should be more predictive of a cardiovascular 
event than non-indexed LVM.55 
No optimal method to account for body size has been firmly established and the issue remains 
controversial.23,31,33,55 Indexing to BSA was the first normalization process used, but it 
underestimates the prevalence of LVH in obese and in overweight hypertensive patients.66 On the 
other hand, when height is used for indexing and weight is not accounted for, as expected, the 
prevalence of LVH is higher in the obese subjects.55 Indexing by height to the allometric power 
of 2.7 (height2.7)  appears to best account for the relationship between height and LVM in 
hypertensive and obese individuals, while it also appears to be less variable among normal 
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subjects, providing a more sensitive cutoff for LVH.52,67,68 Indexing to height2.7 also appears to be 
the method best suited to detect LVH in the presence of acromegaly, particularly among those 
subjects who are also overweight.69  
De Simone et al. conducted two studies comparing different indexing methods of 
echocardiographic LVM assessment. In the first study, they used a population of hypertensive 
individuals with a low prevalence of obesity (22%, with only 3% and 0.1% in class II and class 
III obesity, respectively).66 After adjusting for age and sex, indexing by height, height2.7, or 
height2.13 performed as well as BSA as outcome predictors.   In a second study, the same authors 
followed prospectively an American Indian population free of prevalent CVD at a baseline 
examination, but with a high prevalence of obesity.70   In this study, LVM normalization by 
height to allometric powers performed better than LVM normalization by BSA, as outcome 
predictors, allowing the detection of obesity-related LVH with a worse prognosis that was  
unidentified using BSA and being associated with a higher proportion of incident CVD cases 
attributable to LVH. In addition, the results of this study suggest that the indexation of height to 
allometric powers should be preferable for the identification of high risk LVH individuals in 
populations with high prevalence of obesity, generally mild hypertension and good control of 
blood pressure .70 
As far as CMR assessment of LVH, two studies have been conducted, both using participants 
from MESA, to compare different indexing methods with regards to their prognostic 
performance.27,55,71 Chirinos et al.27 analyzed CMR data from the MESA study and ECHO data 
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from the Asklepios Study72 to assess different metric relationships between LVM and body size, 
and compared the ability of different normalization methods to predict cardiovascular events. 
The authors concluded that the allometric exponent, which adequately described the LVM - body 
height relationship was 1.7 in both studies; this is different from both the unity and the 2.7 
exponents suggested previously. In addition, they found that LVM/height2.7 systematically 
misclassified subjects in regards to the presence of LVH, whereas the LVM-BSA relationship 
seemed to be approximately linear. More specifically, LVM/height2.7 grossly overestimated the 
prevalence of LVH in individuals with shorter body height across genders, while it 
underestimated its prevalence in those with greater body height. Finally, the authors 
demonstrated that LVH defined by LVM/height1.7 was more sensitive than LVM/BSA in the 
identification of obesity-related LVH, and was most consistently associated with cardiovascular 
events and all-cause death. However, only White and Chinese MESA participants and White 
European participants from the Asklepios study were included in the analyses.27 In the second 
study, Brumback et al used MESA participants to develop allometric indices for LVM measured 
by CMR and compared prevalence estimates and LVH predictive values as defined by their new 
indices and the previously defined ones in the MESA study.55 Namely, the authors investigated 
indexation by BSA, height2, height2.7, percent-predicted LVM based on height and sex, and 
percent-predicted LVM based on height, weight, and sex. The authors reported that no 
significant differences were observed in relation to the predictive ability of the indices, while 
LVH prevalence was higher for those indices that did not account for weight.55 
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Table 1.1, adapted from Armstrong et al.30 and Lang et al.31, summarizes different indexing 
methods within and between imaging modalities for LVH classification.  
Total Heart Weight (total cardiac mass) in healthy & diseased hearts !
Significance & Challenges of Assessment  !
Accurate measurements of total heart weight at autopsies used together with appropriate 
reference ranges are considered crucial for pathologists to determine the presence of 
cardiomyopathies.34,73 An elevated heart weight can be suggestive of conditions such as 
hypertensive and valvular heart disease, hypertrophic cardiomyopathy, ischemic heart disease, 
pulmonary hypertension,  and cardiac failure due to various causes.34  Thus, it is of critical 
importance to be able to judge correctly whether an increased weight represents a pathological 
condition or not.    
However, defining cutoffs for cardiomegaly and establishing a firm definition of cardiomegaly 
by consensus, based on the measurement of heart weight, presents a great challenge. The 
scientific evidence available relies largely on older autopsy studies (1970-1990’s) for total 
cardiac mass when the population was shorter and leaner than at present.73-77 In light of the 
increased life expectancy and the undeniable “obesity epidemic” that is a growing global health 
problem, the effects of age and body weight on heart weight need,  to be re-addressed.41,74,78,79 
Another challenge in the calculation of correct reference ranges for heart weight arises from the 
fact that some studies have not excluded hearts with pathologic changes, confounding normative 
data with those from abnormal hearts.73,80!In addition, establishing ethnicity-specific reference 
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standards for heart weight is also important.73,76,81 Overall, it is understood that the reference 
values provided for heart weight can only be valid for a limited period of time and should be 
regularly updated.34,73 
It would be ideal to identify a parameter that correlates well with heart weight, so as to be able to 
use it as a surrogate. Results from older studies suggested that body weight and body height were 
the best predictors of heart weight.34,74,76 On the other hand, recent studies argue that the most 
predictive factor for normal hearts is BSA, while for diseased hearts it is height1.7.34,53,73  
However, the majority of new studies lack statistical significance to prove superior correlations 
of these parameters with heart weight, and thus, body weight is still considered as the best 
surrogate of heart weight;53,73,82!Data from a review of 300 autopsies in a population of older 
patients with multiple comorbidities, suggest that, in males, heart weight is increased only in 
association with BMI and not age, while increasing age and not BMI is associated with LVH.41 
Reference Ranges for Total Heart Weight  !
As indicated above, it is evident that the current reference ranges provided are based on older 
studies and should be updated. The heart weight reference values most cited are based on papers 
from 1942 and 1988, including some data taken from populations more than a century ago.34,74 
Grandmaison et al. in 2001 provided updated reference values for organ weights, including the 
heart, based on a population of French Caucasian individuals with a mean age of 45 years, with 
measures between 1987 and 1991.73 All the adults in the study died from external causes and 
showed no pathological changes. The authors reported mean total cardiac mass for both genders 
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365 (71) g and 312 (78) g for men and women, respectively.73 In a more recent study, Mandal et 
al. aimed to illustrate the effect of obesity on heart weight and thus they provided mean heart 
weight per BMI category. They reviewed 300 full or “no-brain” autopsies between September 
2007 and April 2010, based on a population of older patients with multiple comorbidities, White 
and African Americans, 40% of whom were obese and 29% overweight. For the normal BMI 
category of 18.5-24.9 kg/m2 the mean heart weight was 477±130g and 384±101g, for men and 
women, respectively. In addition, the mean total heart weight was 547±158g and 465±172g for 
men and women, respectively.41 Obviously then, the data from Mandal et al. are likely to be 
confounded  by persons with dabnormal hearts and obesity, which is also a disease state. 
Vanhaebost et al. provided a user-friendly internet application, which computes the predicted 
normal heart weight as a function of body weight.34 In the majority of the studies, the mean heart 
weight was found to be 30-40% greater in men than in women with a similar body weight.34,41,73  
Total heart weight has also been expressed as a percentage of body weight, facilitating 
extrapolations from one to the other and allowing the best use of existing data. In most of the 
relatively recent studies, heart weight represents 0.51% of body weight in both genders,53 
indicating slight differences from previous studies, probably due to the fact that older studies 
may have failed to exclude those participants with hypertension.74,78,79 
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Relationship of LVM to Total Heart Weight  !
Autopsies vary considerably based on the different forms and protocols utilized across various 
jurisdictions. Most autopsies do not report individual ventricular weight, but rather they report 
the total heart weight. Total Heart Weight (THW) consists of many different components, such 
as the epicardial fat, the ventricular weight, and the atrial weight.  Thus, having only THW 
makes it  challenging to reach any firm conclusions about the proportional contribution of the 
LV mass to it.81,83 In addition, the specific measurement technique used by pathologists may add 
challenges in the estimation of the LV weight through the THW, thus producing further 
discrepancies among different pathologists and/or different laboratories.40,73,81,83 
Given the significance of the LVM, we tried to understand better the relationship between LVM 
and THW, based on current data available. Therefore, we made an effort to estimate the 
contribution of the weight of the left ventricle to THW. First, we used the mean values of the 
THW and LVM both by CMR and through pathologists’ measurements from Farber et al., where 
the authors used 55 explanted cardiomyopathy hearts. Autopsy based data suggest that LVM 
contributes 70.3% of the THW while CMR based data suggest that the contribution of the LVM 
to the THW is 66.9% in this population of diseased hearts.61 On the other hand, population-based 
CMR data31 and forensic autopsy cases73 from normal hearts, suggest that LVM contributes only 
around 42% of the THW in men and around 35.5% in women. Unfortunately, very little data is 
currently available to study the relationship between the mass of the left ventricle and the total 
heart weight, suggesting an area urgently in need of future research.  
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The Phenomenon of “Athlete’s Heart” !
An additional controversy surrounding the assessment of LVM relates to adaptive rather than 
pathological  hypertrophy which can occur because of healthy behaviors, such as physical 
training and exercise.23 LVM in some elite athletes can reach twice that of sedentary, but 
otherwise healthy individuals54,84. Athletes may undergo routine medical examinations with 
suspicious electrocardiographic changes, especially for LVH and an  increased LVM that could 
be extremely important for maintaining optimal cardiac performance during training and 
competition. 85Apart from the clinical examination, ECHO remains the principal way of 
differentiating between adaptive and maladaptive cardiac hypertrophy; the athlete’s heart 
typically shows an eccentric biventricular hypertrophy with wall thickness under 15mm and a 
moderately dilated left ventricle, with left ventricular end diastolic diameters up to 58mm.54,86  
A second area of controversy in athletes is whether these adaptive changes are always non-
pathologic. Rowland has raised provocative questions about the arrhythmogenic nature of LVH 
that accompanies athletic training.87 In the absence of definitive pathological stigmata this creates 
further challenges to the definition of normal LVM and thus LVH.88 For instance, if trained 
athletes are included inadvertently in a normal control population, it is more likely that the range 
for LVM and wall thickness will be higher, leading to a decreased sensitivity in actually 
detecting true cardiac abnormalities.85 
The idea that the cardiovascular system of trained athletes differs both structurally and 
functionally from that of untrained, normal individuals due to physiologic adaptation is more 
than 100 years old.54,89-92 Thus, it is apparent, based on the literature, that exercise induces 
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functional and structural changes in the cardiovascular system with the type of training 
(endurance versus strength training) to be of particular importance.54,85,86,93,94 Evidence suggests 
that strength training alone almost never causes physiologic hypertrophy of the heart and thus, if 
hypertrophy is evident, it is highly likely that structural heart disease is present.86  
A heart with moderately increased mass and a high working capacity triggered by the repetitive 
additional cardiac workload which is induced by regular exercise training (longer than 5-6 hours 
a week) and without any serious valvular or other functional disorders is called an “athlete’s 
heart”.86,95,96 In addition, the upper limit for physiological hypertrophy is set between 160-
170g/m2, measured echocardiographically with the Devereux formula.97,98 However, it is 
important to consider that two-dimensional echocardiography is more likely to significantly 
overestimate LVM in untrained as well as highly trained individuals compared with the CMR.97 
Absolute cardiac dimensions are considered to fall outside clinically accepted partition values 
when left ventricular wall thickness is more than 12 mm, with somewhat lower cutoffs for 
female and adolescent athletes.99,100 A maximum left ventricular wall thickness of 15mm in 
young trained athletes represents the upper limit of physiologic LVH.101 However, a significant 
number of patients with hypertrophic cardiomyopathy show no or only mild wall thickening in a 
gray zone of 13 to 15 mm, which overlaps with that found in elite athletes, and thus absolute 
values of wall thickness may not be adequate for differential diagnosis.101,102 Moreover, in 
physiologic hypertrophy of athletes, even though the anterior ventricular septum is usually the 
segment of the LV wall that is maximally thickened, the overall pattern is both symmetric and 
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homogeneous, with a difference of 2mm or less between all portions of the LV.101 
CMR’s role in the differential diagnosis of pathologic hypertrophy from physiologic LV 
remodeling in trained athletes has been receiving a great deal of attention lately. It is often 
superior to ECHO, particularly when increased wall thickness is completely or predominantly 
limited to focal areas of the anterior free wall, posterior septum, and apex.103,104 However, in 
trained athletes with physiologic cardiac remodeling, and in the absence of any localized wall 
thickening, CMR findings indicate right ventricular and left ventricular cavity enlargement of 
normal shape.96 Prakken et al. 80 conducted a study primarily among Dutch Caucasians to 
determine both reference values for endurance athletes based on CMR and the upper limits for a 
physiological adaption to exercise training. The authors concluded that endurance athletes (either 
regular or elite) showed an increase in ventricular volumes, diameters, wall mass, and wall 
thickness, when compared to a healthy population with recreational sports activities. 
Interestingly, regular athletes showed a mean LVM closer to the elite athletes (difference:14 g) 
than to non-athletes (difference: 44g), even though training hours per week of regular athletes 
were half compared to elite ones. Prakken et al. also suggested that a high number of hours per 
week of training and male gender could result in an overlap with standard thresholds for 
cardiomyopathy and recommended the use of the 95th percentile reference values for the standard 
upper limits for the general population.80 
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Conclusions  !
LVH is recognized as a significant clinical and epidemiologic marker of cardiovascular disease. 
Its objective assessment by measuring LVM is considered to improve prognostic accuracy. In 
clinical practice, 2D-guided M-Mode ECHO and 2D ECHO remain the most widely used and 
most accessible imaging modalities for the assessment of LVM, while CMR represents the gold 
standard. Despite many years of research and practice, LVH definitions using LVM cut-off 
reference ranges for LVH assessment demonstrate wide variability among technicians, 
laboratories, and institutions, with a need of greater standardization. In addition, there are only a 
few direct comparisons of ECHO and CMR, and the methods used are currently not cross-
standardized. For both ECHO and CMR, the optimal method of indexing for body size remains a 
controversial issue, affecting the definition of pathological hypertrophy. Another area that 
warrants more research is the overlap of LVM in “athletes’” hearts with abnormal ranges, and 
whether all changes associated with “athletes’” hearts are truly benign. 
 Notwithstanding the known significance of LVM as a marker of LVH and CVD risk, forensic 
studies rarely assess LVM, and instead, they measure routinely total cardiac mass as an indicator 
of potential cardiomegaly. Autopsy investigations clearly support cardiomegaly as a marker of 
CVD and SCD risk. However, very little autopsy data exist to facilitate direct comparisons 
between the mass of the left ventricle and the total cardiac mass, in order to establish a firm 
relationship between the two. The limited data available suggest that LVM accounts for a much 
greater proportion of total cardiac mass in diseased hearts as compared to normal hearts. Another 
important area for future research is the updating of reference ranges for total heart weight in 
light of the contemporary population’s changes in height and weight.  
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Abstract  !
Background: Cardiovascular disease (CVD) accounts for 45% of on-duty deaths in US fire 
service; cardiac enlargement is common among US firefighters; and plays a major role in 
firefighter sudden cardiac death (SCD).  
 
 Aims: To estimate the prevalence of cardiac enlargement in US Firefighters by autopsies, 
echocardiography (ECHO) and cardiac magnetic resonance (CMR).  
 
Methods: In the present cross-sectional study, the prevalence of left ventricular hypertrophy 
(LVH)/cardiomegaly was a) estimated non-invasively among active career firefighters and b) 
examined by reviewing autopsies of firefighters who suffered a non-cardiac, on-duty fatality. 
LVM among active career firefighters was assessed by ECHO and CMR, and normalized 
(indexed) for body surface area (BSA) and height. Autopsy estimates were based on cardiac 
weights and other forensic parameters.  
 
Results: LVH prevalence estimates among active career firefighters presented a range from 
3.3% to 32.8% among ECHO and 0.0% to 5.3% among CMR criteria. LVH was present in 
17.5% and 0.4% of the active firefighters as defined by LVM indexed to height1.7 (by ECHO and 
CMR, respectively). LVM indexed to BSA as measured by CMR indicated zero prevalence of 
LVH. Among non-cardiac traumatic autopsies, prevalence estimates of cardiomegaly and LVH 
were 39.5% (95%CI 33.7–45.3) and 45.4% (95%CI 39.5–51.4) respectively, even after 
adjustment for age and bmi.  
 
! CA!
Conclusions: The prevalence of cardiac enlargement varied widely depending on the imaging 
assessment, the cutoffs and the normalization techniques.  For autopsy data, BMI was a major 
determinant of heart weight. Future CVD-outcome based studies are needed to provide evidence 
for the most accurate cutoffs, while standardization of autopsies is needed across protocols and 
jurisdictions.  
 
Keywords: cardiomegaly, hypertrophy, echocardiography, cardiac magnetic resonance, 
autopsies, fire service  
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Introduction !
 
Firefighting is widely recognized as an inherently dangerous occupation, and more than 1 million 
Americans are involved in this critical public service.1 Intuitively, one may think that most on-
duty deaths result from burns or smoke inhalation, however, cardiovascular disease (CVD) is the 
leading cause of duty related fatalities among firefighters (45% of on-duty fatalities).2-5Moreover, 
for every fatal on-duty CVD event, there are an estimated 25 additional nonfatal CVD events6,7. 
Therefore, CVD events are a problem of paramount importance in the US fire service.  
It is crucial to note, that the risk of on-duty CVD events is not evenly distributed among all 
firefighters, but is highly concentrated among the most susceptible individuals. 2,8 On-duty CVD 
events and heart disease retirements occur primarily in firefighters with underlying disease 
(known or subclinical) or excess cardiovascular risk factors. 9-11 Thus, considering that 
firefighting is very strenuous and can trigger a CVD event in a susceptible individual 2,12,  and 
many hazards cannot be fully avoided or mitigated by engineering/ administrative controls.12 
Much attention has focused on the key prevention question of what can make an individual 
firefighter susceptible. Increasingly, evidence is pointing to a major role of left ventricular 
hypertrophy (LVH)/cardiomegaly in the risk of sudden cardiac death (SCD) independent of the 
presence of Coronary Heart Disease (CHD).13-15   
Left ventricular hypertrophy (LVH)/cardiomegaly is a structural abnormality of the heart16,17 and 
appears to be a key pen-ultimate and predisposing step on the causal pathway that makes a 
firefighter susceptible to CVD events 2,11,18. Cardiomegaly is a general term used to describe 
increased heart size, whereas LVH describes both increased wall thickness and mass, due to a 
thickening of the heart muscle that surrounds the left ventricle. LVH/cardiomegaly has been 
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widely recognized to increase the risk of fatal ventricular arrhythmias, myocardial infarction and 
stroke; and it is a proven predictor of CVD and overall mortality in the general population. 19-23 
Moreover, evidence from studies based on autopsy reports from active career firefighters, 
indicates that LVH/cardiomegaly is common among US firefighters and plays a major role in 
CVD events and SCD risk in the fire service. 9,24  
Notwithstanding, the known significance of LVH/cardiomegaly as a clinical and epidemiologic 
marker of CVD and SCD, its definition demonstrates wide variability among imaging modalities, 
technicians, normalization processes and algorithms. 25-27 Evidence suggests an increasing 
prognostic value, when LVH is based on the accurate assessment of LV mass (LVM). The two 
most frequently used imaging modalities for the non-invasive identification of LVH are 
echocardiography (ECHO) and cardiac magnetic resonance (CMR), with CMR considered the 
gold standard.28 ECHO and CMR use different algorithms for the assessment of LVM, providing 
different average values along with different degrees of accuracy. 25,28 In addition, indexing to 
body size parameters has been the most common normalization process to account for 
anthropometric variation, although the optimal method remains controversial. 27,29 Overall, it is 
important to note that the variability between the imaging techniques, the reference ranges, the 
body size indexing and other adjustments could critically affect the distinctions between disease 
states and normality. In contrast to clinical studies, forensic autopsies rarely assess LVM, and 
instead they routinely measure total heart weight as an indicator of cardiomegaly. With regard to 
LVH, pathologists may measure wall thickness and comment on the appearance of the ventricle. 
The aim of this paper is to estimate the prevalence of cardiac enlargement (including LVH) in 
US firefighters and determine how these prevalence estimates vary according to different 
methods of assessment; namely by autopsies, ECHO and CMR; as well as by the criteria used to 
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define enlargement/hypertrophy. 
Methods !
In the current study we present prevalence estimates of LVH among active career firefighters by 
two imaging techniques (ECHO and CMR). We also compare these with prevalence estimates 
observed by direct measures of heart weight and LV wall thickness at autopsy among formerly 
active firefighters who suffered a non-cardiac fatality while on-duty. 
Study Population (Imaging assessment) !
Male career firefighters, aged 18 years and older were recruited from the Indianapolis Fire 
Department (IFD). Eligible firefighters had no restrictions on duty and had a recorded fire 
department-sponsored medical exam in the last two years that included a submaximal exercise 
tolerance test. 
From those eligible (n=1059), we selected a total of 400 participants, utilizing an “enriched” 
randomization strategy based on age at randomization, obesity, hypertension (HTN) and cardio-
respiratory fitness (CRF) status at last examination, so that a larger number of higher risk 
participants would be selected. Thus, we randomly selected: 100 participants from the entire 
eligible population; 75 low-risk participants (age <40, non-obese, free of HTN and high CRF) 
and 225 higher risk participants (at least 2 of the following: age >/=40, obese, HTN or low CRF) 
for further LVH/cardiomegaly screening and imaging tests. Obesity was defined by standard 
criteria (BMI >/=30 kg/m2). Hypertension was considered present if resting blood pressure is 
>/=140/90 mm Hg. Low CRF was defined as the bottom tertile, as measured by the recorded 
treadmill time and the estimated maximal VO2 during the last exercise test. Those selected were 
included in the study if they had no contraindication to CMR and signed informed consent to 
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participate. Out of the 400 active career firefighters, we excluded 7 participants with missing 
measurements of LVM, as assessed by CMR. 
Definitions of Cardiac Enlargement by Imaging Assessment !
LVM was assessed by both ECHO and CMR imaging. First, a transthoracic cardiac 
echocardiogram was done as a simple two-dimensional (2-D) study with limited m-mode 
recordings. An abbreviated cardiac MRI (CMR) was performed as “function only” immediately 
after the ECHO. Images were obtained using a retrospectively EKG-gated steady-state free 
precession cine sequence. In this fashion, a contiguous short axis stack of 8 mm slices was 
obtained parallel to the atrioventricular groove to cover the entire length of the LV. Then, 
manual tracing of end-diastolic epicardial and endocardial borders was performed. Standard long 
axis views were also obtained including horizontal long axis, vertical long axis, and 3-chamber 
views, facilitating the interpretation of ventricular function. Board certified specialists performed 
the clinical interpretation of imaging.  
LVM indices were derived by dividing LVM in kilograms with either body surface area (in 
meters2) or height to the allometric powers of 1.7 and 2.7 (in meters1.7 and meters2.7, respectively). 
Body surface area was estimated with the Mosteller formula. LVH/cardiomegaly was defined 
based on the cutoff values presented in Table 2.1, for posterior and septal wall thickness, LVM 
and LVM indices. 
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Table 2.1: Definition of Cardiomegaly/Left Ventricular Hypertrophy, by both Imaging 
Modalities (echocardiography and cardiac magnetic resonance) and Autopsies. 
 
 
Cutoff Values for Cardiomegaly/Left Ventricular Hypertrophy 
ECHO/CMR 
 
Posterior wall thickness (cm) 
 
!1.2 
Septal thickness (cm) !1.2 
ECHO 
 
 
LVMi _BSA (g/m2) 
 
 
>115 
LVMi _Height1.7 (g/m1.7) >81 
LVMi _Height2.7 (g/m2.7) >50 
LVM (g)  
 
>225 
CMR 
LVMi _BSA (g/m2) >106.2 
LVMi _Height1.7 (g/m1.7) >80 
LVMi _Height2.7 (g/m2.7) >45.1 
LVM (g) >203.5 
Autopsy 
Reports 
 
 
 
Quantitative Definitions 
Heart Weight (g) ! 450 
LV wall thickness (cm) !1.2 
 
Qualitative Definitions 
 
Heart size abnormality noted 
 
 
YES 
Increased Wall Thickness noted  
 
 
YES 
 
Comprehensive definitions 
Cardiomegaly  
 
! 450 and/or YES 
Left Ventricular Hypertrophy  
 
!1.2 and/or YES 
LVMi, Left Ventricular Mass index; LVM, left ventricular mass; ECHO, echocardiography; CMR, cardiac magnetic 
resonance. 
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Assessment of Cardiovascular Risk Factors  !
Height was measured in the standing position with a clinical stadiometer. Body weight was 
measured with bare feet and in light clothes on a calibrated scale. BMI was calculated as the 
weight in kilograms divided by the square of height in meters. Blood pressure was measured 
using an appropriately sized cuff with the subject in the seated position. Heart rate and blood 
pressure were obtained in a resting state from the physical examination (and were not measured 
prior to the exercise test). Medical exam data were further supplemented by a pre-imaging 
questionnaire, which collected comprehensive information on smoking status, personal history of 
heart rhythm problems, family history of cardiac problems, self-reported HTN and moderate to 
vigorous physical activity level in minutes per week. High Obstructive Sleep Apnea (OSA) risk 
was assessed using the widely used and validated Berlin Questionnaire.30 
 
Direct measures of Heart weight and wall thickness based on autopsy reports !
Non-cardiac traumatic fatalities (deaths due to blunt trauma, burns, or asphyxiation) were 
identified for 2006 to 2012 from a firefighter autopsy research data bank maintained by the 
National Fallen Firefighters Foundation. The inclusion criteria for the non-cardiac trauma 
controls were (1) age " 65 years, (2) duty-related death, and (3) cause of death determined by 
autopsy to be due to blunt trauma, burns, or asphyxiation and not related to any cardiovascular 
pathologic entity.  For the purpose of this study, we used only male autopsy reports from those 
eligible.  
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Definitions of Cardiac Enlargement based on autopsy reports !
 
We defined LVH and cardiomegaly from autopsy data, based on both qualitative and quantitative 
criteria. (Table 2.1) Qualitative definitions were based on the conclusions documented in the 
autopsy report. Qualitatively, we considered cardiomegaly present if the autopsy report indicated 
a heart size abnormality, and LVH present if the autopsy reported an increased wall thickness.  
Quantitative definitions were based on the reported values of LV wall thickness and heart 
weight. Quantitatively, we defined cardiomegaly as a heart weight ! 450 g and LVH as a LV 
wall thickness ! 1.2 cm.  The cutoff values of 1.4cm and 1.7cm were also used in analyses for 
LV wall thickness. In the absence of qualitative or quantitative information on LV wall thickness 
and/or heart weight, we classified the deceased individuals as not affected by LVH or 
cardiomegaly. The qualitative and quantitative definitions for LVH and cardiomegaly were not 
mutually exclusive and therefore we created a comprehensive definition as well; more 
specifically, all subjects who met the criteria for the qualitative and/or the quantitative definitions 
were classified as affected by LVH or cardiomegaly   under the comprehensive definition.  
 
Data from 353 autopsy reports were available.  We conducted our main analysis with data from 
293 autopsy records, excluding those with missing information on BMI. We also performed a 
series of sensitivity analyses with data from all 353 autopsy records, where the prevalence rates 
of LVH and cardiomegaly were estimated assuming a BMI of 25 kg/m2 and then 27 kg/m2 for all 
records with missing information. Under the assumption based on that the pathologists would 
have reported the weight in the autopsies if this was in the obesity range, we set the values of 
BMI for sensitivity analyses to fall either in the normal/ overweight range. 
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Statistical Analysis !
We performed a weighted analysis regarding the imaging data so as to account for our enriched 
randomization sampling strategy. Weights were calculated based on the total number of risk 
factors per subject with the technique of inverse probability weighting (Appendix table 2.1). 
Baseline characteristics were described using the mean (SD) for quantitative variables and the 
frequency (%) for categorical variables. Prevalence estimates for LVH based on ECHO and 
CMR assessments were presented as percentages (95% CI). Comparisons of prevalence 
estimates between paired data were performed with the McNemar’s test.  
 
Prevalence estimates of LVH and cardiomegaly based on autopsy records were adjusted for age 
and BMI according to the age and BMI distributions of the active career firefighter population 
using the method of direct standardization. Age was classified in 10-years classes (26-35, 36-45, 
46-55, 56-65) while BMI was categorized as normal (BMI<25 kg/m2), overweight (25<BMI <29 
kg/m2), obesity class I (30<BMI<34 kg/m2), obesity class II/III (BMI!35 kg/m2). Agreement 
between the qualitative and the quantitative definitions applied to detect cardiomegaly and LVH 
among autopsy records was evaluated using the Cohen’s kappa. The significance of the trend 
across ordered groups of ages or BMI was evaluated with the use of the score test under a linear 
trend of odds.  
Analyses were performed using SPSS, version 21.0 (IBM, Armonk, New York) and Stata, 
version 14.0 (StataCorp, College Station, Texas). A p-value < 0.05 was considered statistically 
significant and all tests performed were two-sided.  
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Results !
The baseline characteristics are summarized in Table 2.2. After adjusting for the weighted 
sampling strategy, the mean age of active career firefighters was 45.3 years (SD 8.1) and their 
mean BMI was 30.3 kg/m2 (SD 4.5). There were 41.3% with family history of cardiac problems, 
44.8% were obese, 31.6% had high risk of OSA based on the Berlin Questionnaire and 34.3% 
had low CRF. The mean LVM measured was 186.9 grams (SD 36.6) by ECHO, and 137.6 grams 
(SD 23.4) by CMR. Among autopsy data, the mean age at death was 42.7 years (SD 10.3) and 
the mean BMI at death was 31.2 kg/m2 (SD 6.9). The mean heart weight at death was 438 grams 
(SD 99) while the average LV wall thickness (LVWT) was 0.9 cm (SD 0.4cm). 
The prevalence estimates of LVH by both ECHO and CMR assessment based on different 
criteria are summarized in Table 2.3. Great variability was observed within ECHO based on 
different definitions/indices applied. Across ECHO assessment, 14.1% of active career 
firefighters demonstrated LVH based on LVM, 13.1% based on posterior wall thickness and 
32.8% based on septal wall thickness. Considering the CMR measurements, 5.3% of the career 
firefighters studied were identified as having LVH, as defined by posterior wall thickness. When 
considering definitions based on LVM normalized to height to the power of 1.7, LVH was 
present in 17.5% and 0.4% of the active career firefighters (ECHO and CMR, respectively). 
Normalization by BSA using CMR measurements was the only criterion to deliver zero 
prevalence of cardiac enlargement. Overall, higher values of LVM and therefore, LVH 
prevalence were observed among ECHO measurements compared to CMR.  
 
All comparisons of LVH prevalence estimates obtained by ECHO were significantly different 
(p<0.05) based on varying definitions, while within CMR measurements the estimates showed 
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similarity (p=0.125), only when definitions were based on the height indices (height1.7 vs. 
height2.7). Comparisons of LVH prevalence between ECHO and CRM were significantly 
different (p<0.001) for estimates based on LVM, PWT and indexing to height1.7. 
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Table 2.2: Baseline descriptive characteristics. 
Variables Imaging Study Sample 
Imaging Study 
Sample 
Unweighted 
Autopsy Data 
  (N= 393)      (N=293) 
Age years † 46.5 ± 8.2 45.3 ± 8.1 42.7 ± 10.3 
Height inches † 70.3  ± 2.5 70.3  ± 2.6 70.1 ± 3.9 
Heart Rate bpm † 80.5 ± 13.4 79.5 ± 13.0 NA 
Resting SBP mmHg †  126.3 ± 9.7 125.2 ± 9.4 NA 
Resting DBP mmHg † 81.8 ± 8.1 81.3 ± 7.4 NA 
Self-reported HTN * 95 (24.7) 225 (21.6) NA 
High Risk of OSA * 112 (38.1) 254 (31.6) NA 
Body Mass Index kg/m2 † 31.1 ± 4.6 30.3 ± 4.5 31.2 ± 6.9 
Smoking * 50 (13.0) 135 (12.9) NA 
Personal History of Heart Rhythm Problems 
* 60 (15.7) 153 (14.7) NA 
Family History of cardiac problems* 153 (40.2) 426 (41.3) NA 
Age >= 40 years * 301 (78.2) 770 (72.7) 172 (58.7) 
BMI>= 30 kg/m2 * 260 (56.1) 474 (44.8) 142 (48.5) 
Low CRF * 178 (46.7) 363 (34.3) NA 
MVPA Physical Activity min/week † 177.4 ± 117.3 187.3 ± 117.7 NA 
Cardiac Measures 
LVM_ECHO g † 189.0 ± 38.1 186.9 ± 36.6 NA 
LVM_CMR g † 139.2 ± 24.0 137.6 ± 23.4 NA 
Heart weight g † NA NA 438 ±99 ‡ 
LVM_ECHO indexed to height1.7 g/m1.7 † 70.4 ± 13.3 69.7± 12.9 NA 
LVM_ECHO indexed to height2.7 g/m2.7 † 39.5 ± 7.6 39.1 ± 7.4 NA 
LVM_ECHO indexed to BSA g/m2  † 85.3 ± 14.5 85.4 ± 14.5 NA 
LVM_CMR indexed to height1.7 g/m1.7 † 52.0 ± 8.3 51.4 ± 8.1 NA 
LVM_CMR indexed to height2.7 g/m2.7 † 29.2 ± 4.7 28.8 ± 4.6 NA 
LVM_CMR indexed to BSA g/m2  † 62.6 ± 8.7 62.8 ± 8.7 NA 
Posterior wall Thickness_ECHO cm † 1.03 ± 0.1 1.02 ± 0.1 NA 
Posterior wall Thickness_CMR cm † 0.93  ± 0.2 0.92  ± 0.2 0.9 (0.4) § 
Septal wall Thickness_ECHO cm † 1.12 ± 0.1 1.11 ± 0.1 NA 
        
SBP, systolic blood pressure; DBP, diastolic blood pressure; HTN, hypertension; OSA, obstructive sleep apnea; 
BMI, body mass index; CRF, cardiorespiratory fitness; MVPA, Moderate to Vigorous Physical Activity; LVM, left 
ventricular mass; ECHO, echocardiography; CMR, cardiac magnetic resonance. † Mean (SD) for continuous 
variables; * n (%) for categorical variables. Low CRF was defined as the lowest tertile, as measured by the recorded 
treadmill time and the estimated maximal VO2 during the last exercise test. ‡Information available in 251 (85.7%) 
autopsy records.  §Information available in 139 (47.4%) autopsy records, a value of 0.9 was imputed for missing 
data. 
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Table 2.3: Prevalence estimates of left ventricular hypertrophy (LVH) by echocardiography and 
cardiac magnetic resonance.  
 
   
                          LVH  (n,%) 
 
Study Study 
 Sample  Sample  
(N=393) Unweighted 
ECHO LVM 58 (15.3) 146 (14.1) 
 
Posterior Wall 
Thickness 61 (16.0) 136 (13.1) 
 
Septal Wall 
Thickness 140 (36.7) 341 (32.8) 
 
LVM/BSA  13 (3.4) 34 (3.3) 
 
LVM/Height1.7 70 (18.7) 181 (17.5) 
 
LVM/Height2.7 34 (9.1) 90 (8.7) 
    CMR LVM  4 (1.1) 9 (1.0) 
 Posterior Wall 
Thickness 21 (6.0) 50 (5.3) 
 BSA 0 (0.0) 0 (0.0) 
 Height1.7 2 (0.6) 3 (0.4) 
  Height2.7 1 (0.3) 2 (0.2) 
 
LVM, left ventricular mass; BSA, body surface area; ECHO, echocardiography; CMR, cardiac magnetic resonance.
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LVH and cardiomegaly distributions by age and BMI categories and based on quantitative 
definitions among the non-cardiac traumatic autopsies are presented in table 2.4. Prevalence rates 
steadily increased with increasing age and BMI.    
 
Unadjusted prevalence estimates (based on comprehensive definitions) showed cardiomegaly to 
be present in 41.3% (n=121) of non-cardiac traumatic fatalities and LVH in 45.5% (n=135). The 
agreement between the unadjusted qualitative and quantitative definitions was low for both 
cardiomegaly and LVH  (Cohen’s kappa 0.35 and 0.18, respectively), while 28.3% of the 
autopsies reported both LVH and cardiomegaly, based on the comprehensive definitions 
(Appendix table 2.2).  An age- and BMI-adjusted prevalence estimate of cardiomegaly 
(comprehensive definition) as high as 39.5% (95%CI 33.7–45.3) was documented among the 
non-cardiac traumatic firefighter fatalities (Appendix table 2.3), while the age- and BMI-adjusted 
prevalence estimate of LVH (comprehensive definition) was 45.4% (95%CI 39.5–51.4) 
(Appendix table 2. 4). The prevalence estimates of cardiomegaly and LVH did not change 
considerably in either of the sensitivity analyses conducted (results shown for BMI=27 in 
appendix tables 2.5 and 2.6). 
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Table 2.4: Distribution of LVH and cardiomegaly by age and body mass index by autopsy 
reports. 
 
a Score test for linear trend of odds 
 
 
Discussion !
The results from the present study in US firefighters demonstrate great variability of the 
prevalence estimates of LVH within and between ECHO and CMR, according to the different 
criteria utilized. Considerable variance was also observed using direct measures at autopsy, 
again, depending on the criteria used. Additionally, autopsy findings clearly indicated that BMI 
was a major determinant of heart weight. Prevalence estimates of LVH were significant, though 
realistic when based on LVM indices and assessed by ECHO. Although CMR is considered to be 
the gold standard among imaging techniques, the prevalence estimates of cardiac enlargement 
observed in the present study seemed unrealistically low, especially when compared to direct 
measures at autopsy in a similar firefighter population. Given the great variance in LVM and 
LVH estimates, surprisingly, the average LV wall thickness was similar across both imaging 
techniques and at autopsies. 
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Taken together, our results reflect the lack of standardization among definitions of cardiac 
enlargement, and therefore, prevalence estimates were highly variable depending critically on the 
choice of the normalization technique, the imaging modality and the cutoff values. Among the 
non-cardiac traumatic fatalities, the comprehensive estimates for prevalence of cardiomegaly and 
LVH were quite high, even after adjustment for age and BMI (39.5% and 45.5%, respectively). 
To the best of our knowledge, our study is the first to evaluate the prevalence of cardiac 
enlargement among active career firefighters by both ECHO and CMR measurements based on 
different criteria, as well as the first to compare these estimates to those derived from non-
cardiac traumatic fatalities. 
We previously found the prevalence of cardiomegaly to be 22% in a smaller sample of non-
cardiac, traumatic firefighter fatalities limited to those under the age of 45 years of age.31 Our 
estimates for these age groups were similar, 27% and 24% for those under the age of 35 and 45 
years of age respectively. 
 
Prevalence estimates of LVH were substantially higher when ECHO measurements were 
considered as compared to CMR. Nonetheless, great variability was still observed among ECHO 
prevalence estimates.  This could be explained by the fact that the measurement of LVM, which 
was the main and single variant component of calculating LVM indices was on average 49.3 
grams higher by ECHO than by CMR. Our findings are in general agreement with previously 
published literature regarding the controversies surrounding the LVM assessment and thus the 
definition of LVH based on imaging.28,29 Along the same lines, current evidence suggests that 
CMR consistently yields lower average values compared to ECHO for the same subjects.32,33 
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Taken together this wide range of prevalence estimates of cardiac enlargement that was observed 
among the same subjects, could be explained in large by the fact that the cut off values used by 
each criterion are very close between the  ECHO and the  CMR measurements, indicating the 
urgent need of adjustments that should be made in these cutoffs. Given the large differences in 
mean LVM consistently observed between ECHO and CMR, it is puzzling that suggested LVH 
cutoff values are so close for the two different imaging techniques. 
Considering all the different values of the prevalence estimates based on imaging assessments, 
taken together with the high prevalence of obesity and CVD risk factors among active career 
firefighters and autopsy-derived direct measures, we believe that our results suggest that the 
estimates provided based on CMR are likely to be unrealistically low, while those provided by 
LVM indexed to height and based on ECHO seem to be more realistic.  
 
Our results are in line with current evidence from previous studies. First when cardiac 
enlargement is assessed by imaging, normalization to anthropometric parameters should be in 
place, so as to minimize the influence of body size in the estimates provided and provide more 
accurate estimates. 27,28,34 Second, evidence suggests that height to an allometric power best 
accounts for the relationship between height and LVM, being less variant among subjects with 
normal BMI and more accurate among those overweight or obese. Therefore, indexing to height 
is a more optimal method than BSA as a means to index for body size. Third, evidence based on 
both ECHO and CMR assessments suggests height to the allometric power of 1.7 to be the 
preferred indexing coefficient for both imaging modalities.27,29 This suggestion is supported by 
our autopsy results. Considering that autopsies are providing a direct measure of assessment and 
are the gold standard criterion, in this study we have found that the prevalence estimates of LVH 
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among obese non-cardiac fatalities to be around 40% (Appendix Table 2.4). Therefore, we would 
not expect prevalence much lower than that in an active group of firefighters with high 
prevalence of obesity, OSA and HTN. The only index that showed closer prevalence estimates to 
the ones provided by autopsies was the one based to height 1.7  (17.5%). Our results also suggest 
that normalization by BSA is less likely to be appropriate for an obese population like 
firefighters, since it is considered that including BSA in the index in a way we account for body 
weight and thus indexing to BSA leads to a gross underestimation of cardiac enlargement among 
obese and overweight individuals.27,34 This is also supported by our results, where the prevalence 
estimates provided by indexing to BSA were null, which is difficult, if not impossible to believe 
given the population’s risk profile.  
 
Among traumatic deaths, where any possible contribution of cardiac pathology to the death was 
reasonably excluded, around 40% demonstrated cardiomegaly while approximately 50% 
presented LVH. This can be explained in large by the high prevalence of obesity that was 
documented among those noncardiac traumatic controls, while in addition our results suggested 
the prevalence of cardiac enlargement to be steadily increasing as a function of BMI.  Our 
findings are consistent with the literature, which finds obesity to be a significant risk factor for 
LVH and increased cardiac mass.2,24 Furthermore, one could hypothesize that traumatic fatalities 
occur more frequently in obese firefighters as they could be more inclined to be physically 
trapped during a fire secondary to their body size and relative physical immobility. 31 In fact, the 
average BMI of the non-cardiac fatalities was higher than that of the active firefighter study base 
population (31.2 vs. 30.3) and that previously reported for representative, population-based 
firefighter samples (28.6 for career firefighters).35 
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One limitation of the data and therefore, of the current study is the fact that we were not able to 
conduct direct comparisons between heart mass or LVM in autopsies and clinical imaging, with 
imaging modalities focusing on the determination of cardiac enlargement via LVM assessment, 
and autopsies using total heart weight.  None of the autopsies reviewed in the present study 
reported individual ventricular weights, but rather only the total heart weight. However, total 
heart weight consists of many different components, such as the epicardial fat, the ventricular 
weight, and the atrial weight, and therefore, having only measurements for total heart weight 
makes it  challenging to reach any firm conclusions about the proportional contribution of the 
LV mass.36,37  
 
Another limitation of our study is the low correlation between the quantitative, qualitative and 
comprehensive definitions of LVH and cardiomegaly among autopsy reports, due to the fact that 
autopsies vary considerably based on different forms and protocols utilized across various 
jurisdictions.  It seems from current data that values on LV wall thickness and heart weight were 
more likely to be reported if they were relatively high, while sometimes instead of the value 
itself the medical examiner/coroner only reported qualitatively for the presence of hypertrophy 
and/or enlargement without giving an actual value. Considering that heart weight and LV wall 
thickness are valuable criteria, it is really important to ensure that actual values would be 
reported through standardization of the forms of the autopsy reports, in order to be able to be 
used for current and future comparisons.  
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A major strength of our study was the fact that we had access not only to data from active career 
firefighters, but also to autopsy reports from non-cardiac traumatic fatalities. In addition, our 
autopsy findings result rely mostly on quantitative data, with heart weight measurement reported 
in almost 90% of the non-cardiac autopsy reports examined.  Taken together, we were able to 
evaluate the status of cardiac enlargement in the US fire service via many different assessments 
and get a more holistic picture of the current estimates.  
 
Second, we were then able to make direct comparisons of prevalence estimates based on the 
same definitions within and between ECHO and CMR. This was important since there are only a 
few direct comparisons of ECHO and CMR prevalence estimates of cardiac enlargement, and the 
methods used are currently not cross-standardized. Another strength of our study is our age- and 
BMI- adjustment for the prevalence based on autopsies. Since, the use of non-cardiac trauma 
deaths for the purpose of this study was intended to find firefighters whose hearts reflect those of 
the whole population and in fact, our “control” population seemed to still be biased towards 
obesity, adjusting for age and BMI distributions for an actual working firefighter population 
should balance any introduced bias, providing realistic estimates. In addition we used the 
definition of 1.2 cm for defining LVH based on LV wall thickness, considering a more 
conservative approach to avoid any overall with physiologically enlarged hearts due to athletic 
training.  
 
The present results, taken together reveal the huge potential impact of the choices of the 
clinicians/ researchers on defining cardiac enlargement, affecting greatly estimates of cardiac 
enlargement in the US fire service, and creating great challenges on which decisions are the most 
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accurate and appropriate in clinical practice. Irrespectively of the variability in prevalence 
estimates, our study clearly revealed BMI as a major driver of heart weight. In addition, LVM is 
considered as a more global assessment of the size of the left ventricle as opposed to wall 
thickness that could be considered a snapshot, and overall our results suggest the great need for 
CVD-outcomes’ based studies that will provide definite evidence about the most accurate 
normalization indices and cutoffs; while another important area for future research could be the 
updating of reference ranges for total heart weight in light of the contemporary population’s 
changes in height and weight. Furthermore, ECHO screening could be considered to evaluate 
possible cardiac enlargement, based on clinical judgment and the prevalence of CVD risk 
factors, such as stage 1 and 2 HTN, obesity, risk of OSA and age, as a relatively simple and 
inexpensive screening tool and based primarily on LVM indexed to height as most supported by 
the literature.  
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Appendix 
Table 2.1: Distribution of Risk Factors and calculation of weights based on Inverse Probability 
Weighting.  
Number of Risk Factors Study sample  
N (%) 
Study base  
N (%) 
0 48 (12.6) 161 (15.20) 
1 82 (21.5) 367 (34.66) 
2 122 (32.0) 298 (28.14) 
3 
 
103 (27.0) 172 (16.24) 
4 
 
26(6.8) 61 (5.76) 
Weights per number of Risk Factors 
 Sampling Fractions Weights 
(Probability)  
0 48/161 161/48 
(3.354) 
1 82/367 367/82 
(4.475) 
2 122/298 298/122 
(2.443) 
3 103/172 172/103 
(1.670) 
4 26/61 61/26 
(2.346) 
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Table 2.2: Agreement between the qualitative and the quantitative definitions of cardiomegaly 
and left ventricular hypertrophy.  
 
                
Cardiomegaly 
 Quantitative definition  
Qualitative 
definition Negative Positive Total 
Negative 172 (58.7%) 61 (20.8%) 233 (79.5%) 
Positive 18 (6.1%) 42 (14.3%) 60 (20.5%) 
Total 190 (64.8%) 103 (35.2%) 293 (100%) 
 
Cohen’s kappa: 0.35 (95%CI 0.24–0.46) 
Left ventricular hypertrophy 
 Quantitative definition  
Qualitative 
definition Negative Positive Total 
Negative 158 (53.9%) 91 (31.1%) 249 (85.0%) 
Positive 14 (4.8%) 30 (10.2%) 44 (15.0%) 
Total 172 (58.7%) 121 (41.3%) 293 (100%) 
 
Cohen’s kappa: 0.18 (95%CI 0.09–0.28) 
        Cardiomegaly and/or left ventricular hypertrophy 
 Left ventricular hypertrophy 
(comprehensive definition) 
 
Cardiomegaly 
(comprehensive 
definition) Negative Positive Total 
Negative 120 (41.0%) 52 (17.7%) 172 (58.7%) 
Positive 38 (13.0%) 83 (28.3%) 121 (41.3%) 
Total 158 (53.9%) 135 (46.1%) 293 (100%) 
 
Cohen’s kappa: 0.38 (95%CI 0.27–0.48) 
*Data from 293 autopsies records. 
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Abstract  !
Objective: Left ventricular mass (LVM) is a strong predictor of cardiovascular disease (CVD) 
events; increased LVM is common among US firefighters; and plays a major role in firefighter 
sudden cardiac death (SCD). We aim to identify significant predictors of LVM among 
firefighters. 
Methods: Cross-sectional study of 400 career male firefighters selected by an enriched 
randomization strategy. Weighted analyses were performed based on the total number of risk 
factors per subject with inverse probability weighting. LVM was assessed by echocardiography 
(ECHO) and cardiac magnetic resonance (CMR), and normalized (indexed) for height. CVD risk 
parameters included resting vital signs, body mass index (BMI)-defined obesity, risk of 
obstructive sleep apnea (OSA), low cardiorespiratory fitness (CRF), self-reported hypertension 
(HTN) and physical activity. Linear regression models were performed. 
Results: In multivariate analyses, BMI was the only consistent significant independent predictor 
of LVM indices (all, p<0.001). A 1-unit decrease in BMI was associated with 1 unit (kg/m1.7) 
reduction of LVM/ height 1.7   after adjustment for age, HTN, OSA risk and cardiorespiratory 
fitness.  
Conclusions:  After height-indexing ECHO- and CMR-measured LVM, BMI was found to be a 
major driver of LVM among firefighters. Our findings taken together with previous research 
suggest that reducing obesity will improve CVD risk profiles and decrease on-duty CVD and 
SCD events in the fire service. Our results also support targeted noninvasive screening for LVH 
with ECHO among obese firefighters.  
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Background  
 
Cardiovascular disease (CVD) is the leading cause of on-duty death among firefighters (45% of 
on-duty fatalities) and a major cause of morbidity. Moreover, 905 nonfatal on-duty CVD events 
were reported in 2014, such that for every fatal on-duty CVD event, there are an estimated 25 
additional nonfatal events.1,2 As in the general population, these cardiovascular events are largely 
due to coronary heart disease (CHD), 3-6 however, there is an increasing recognition of the role of 
left ventricular hypertrophy (LVH)/cardiomegaly in the risk of sudden cardiac death (SCD) 
independent of the presence of CHD.7-10 
It is crucial to note though, that the risk of on-duty CVD events is not evenly distributed among 
all firefighters, but is highly concentrated among the most susceptible individuals. 3,11 On-duty 
CVD events and heart disease retirements occur primarily in firefighters with underlying disease 
(known or subclinical) or excess cardiovascular risk factors. 12-14 Thus, considering that 
firefighting is an inherently dangerous occupation and many of its hazards cannot be engineered 
out of the job15, key prevention questions focus on what can make an individual firefighter 
susceptible as well as what is the prognostic value of the known CVD risk factors.   
LVH/cardiomegaly is a structural abnormality of the heart16,17 and appears to be a key pen-
ultimate and predisposing step on the causal pathway that makes a firefighter susceptible to CVD 
events.3,14,18 LVH/cardiomegaly has been widely recognized to increase the risk of lethal 
ventricular arrhythmias, myocardial infarction and stroke; and it is a proven predictor of CVD 
and overall mortality in the general population, but it has not been adequately researched in the 
fire service.19-23  Current evidence from studies based on autopsies from active career firefighters 
indicates that LVH/cardiomegaly is common among US firefighters, often co-morbid with CHD 
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and plays a major role in CVD events and SCD risk in the fire service. 12,24 
Evidence suggests an improved prognostic value, when LVH is based on the accurate assessment 
of Left Ventricular Mass (LVM).25 LVM has been also shown to be a strong predictor of 
cardiovascular events among individuals without20,26,27 and with prior coronary heart disease28,29 
and those with heart failure16,30. An increase in LVM is associated with a higher incidence of 
cardiovascular events, including death, while a decrease is a marker of lower risk for 
cardiovascular events, especially among patients on anti-hypertensive treatment.31,32  
Despite the critical prognostic significance of LVM, its measurement and role in clinical practice 
have yet to be established. 33 Echocardiography (ECHO) and cardiac magnetic resonance (CMR) 
are the two most commonly used imaging modalities for the assessment of LVM. Even though, 
CMR is considered the gold-standard for assessing LVM, ECHO is a well validated, non-
invasive method that is more widely used in clinical practice.34   In addition to considering 
different imaging modalities, disagreement exists as to the most appropriate method of indexing 
LVM to body size parameters. 25 Current evidence suggests indexing by height to the allometric 
powers of 1.7 and 2.7 are the most accurate normalization techniques. 33,35,36   
The aim of this paper is to identify the most important predictors of LVM after indexing for 
height among career male firefighters as assessed by both ECHO and CMR.  
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Methods !
Study Population !
Male career firefighters, aged 18 years and older were recruited from the Indianapolis Fire 
Department (IFD). Eligible firefighters had a recorded fire department-sponsored medical exam 
in the last two years that included a submaximal exercise tolerance test, and had no restrictions 
on duty.   
From those eligible, we selected a total of 400 participants, utilizing an “enriched” 
randomization strategy based on age at randomization, obesity, hypertension (HTN) and cardio-
respiratory fitness (CRF) status at last examination, where a larger number of higher risk 
participants could be selected. Thus, we randomly selected: 100 participants from the entire 
eligible population; 75 low-risk participants (age <40, non-obese, free of HTN and high CRF) 
and 225 higher risk participants (at least 2 of the following: age >/=40, obese, HTN or low CRF) 
for further LVH/cardiomegaly screening and imaging tests. Obesity was defined by standard 
criteria (BMI >/=30 kg/m2). Hypertension was considered present if resting blood pressure is 
>/=140/90 mm Hg. Low CRF was defined as the bottom tertile, as measured by the recorded 
treadmill time and the estimated maximal VO2 during the last exercise test. Those selected were 
included in the study if they had no contraindication to CMR and signed informed consent to 
participate.  
Left Ventricular Mass !
LVM was assessed by both ECHO and CMR imaging. First, a transthoracic cardiac 
echocardiogram was done as a simple two-dimensional (2-D) study with limited m-mode 
recordings. An abbreviated cardiac MRI (CMR) was performed as “function only” immediately 
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after the ECHO. Images were obtained using a retrospectively EKG gated steady-state free 
precession cine sequence. In this fashion, a contiguous short axis stack of 8 mm slices was 
obtained parallel to the atrioventricular groove to cover the entire length of the LV. Then, 
manual tracing of end-diastolic epicardial and endocardial borders was performed. Standard long 
axis views were also obtained including horizontal long axis, vertical long axis, and 3-chamber 
views, facilitating the interpretation of ventricular function. Board certified specialists performed 
clinical interpretation of imaging. LVM indices were derived by dividing LVM in kilograms 
with height to the allometric powers of 1.7 and 2.7 (in meters1.7 and meters2.7, respectively). 
 
Assessment of Cardiovascular Risk Factors  !
Height was measured in the standing position with a clinic stadiometer. Body weight was 
measured with bare feet and in light clothes on a calibrated scale. BMI was calculated as the 
weight in kilograms divided by the square of height in meters. Blood pressure was measured 
using an appropriately sized cuff with the subject in the seated position. Heart rate and blood 
pressure were obtained in a resting state from the physical examination (and were not measured 
prior to the exercise test). Medical exam data were further supplemented by a pre-imaging 
questionnaire, which collected comprehensive information on smoking status, personal history of 
heart rhythm problems, family history of cardiac problems, self-reported HTN and moderate to 
vigorous physical activity level in minutes per week. High OSA risk was assessed using the 
widely used and validated Berlin Questionnaire.37 
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Statistical Analysis !
We performed a weighted analysis so as to account for our enriched randomization sampling 
strategy. Weights were calculated based on the total number of risk factors per subject with the 
technique of inverse probability weighting (Appendix table 3.1). Baseline characteristics were 
described using the mean (SD) in the case of quantitative variables and the frequency (%) for 
categorical variables. The effects of the different independent variables on the LVM indices were 
assessed with the use of linear regression models. Any independent variables that were 
significant in the univariate regression models were included in the multivariate regression 
models. In the multivariate analysis, we followed the backward stepwise elimination process 
with a removal criterion of alpha=0.20. Then, considering the predictors that resulted from the 
backward elimination process and variables that we knew a priori to be important clinical 
predictors, we constructed the final multivariate regression models. The interaction effects 
between BMI with OSA and age were also assessed in these models. Collinearity was evaluated 
using the variance inflation factor. Analyses were performed using SPSS version 21.0 (IBM, 
Armonk, New York). A p-value of  < 0.05 was considered statistically significant and all tests 
performed were two-sided.  
Results  !
Out of the 400 firefighters, we excluded 7 participants with missing measurements of LVM, 
assessed by CMR. Baseline characteristics are summarized in Table 3.1. The mean age of the 
study subjects was 45.3 (8.1) years and their mean BMI was 30.3 (4.5) kg/m2. There were 41.3% 
with a family history of cardiac problems, 44.8% were obese, 31.6% had high risk of OSA and 
34.3% had low CRF. The mean LVM measured was 186.9 (36.6) grams by ECHO, and 137.6 
(23.4) grams by CMR, respectively.  
!                                                                                                                                              
 
! GA!
Table 3.1: Baseline descriptive characteristics. 
 
Variables 
 
 Study Sample 
 
(N= 393) 
Study Sample  
Weighted 
 
Age years † 46.5 ± 8.2 45.3 ± 8.1 
Height inches † 70.3  ± 2.5 70.3  ± 2.6 
Heart Rate bpm † 80.5 ± 13.4 79.5 ± 13.0 
Resting SBP mmHg †  126.3 ± 9.7 125.2 ± 9.4 
Resting DBP mmHg † 81.8 ± 8.1 81.3 ± 7.4 
Self-reported HTN * 95 (24.7)  225 (21.6)  
High Risk of OSA * 112 (38.1)  254 (31.6)  
Body Mass Index kg/m2 † 31.1 ± 4.6 30.3 ± 4.5 
Smoking * 50 (13.0)  135 (12.9)  
Personal History of Heart Rhythm 
Problems * 
60 (15.7)  153 (14.7)  
Family History of cardiac problems* 153 (40.2)  426 (41.3)  
Age >= 40 years * 301 (78.2)  770 (72.7)  
BMI>= 30 kg/m2 * 260 (56.1)  474 (44.8)  
Low CRF * 178 (46.7)  363 (34.3)  
MVPA Physical Activity min/week † 177.4 ± 117.3 187.3 ± 117.7 
LVM_ECHO g † 189.0 ± 38.1 186.9 ± 36.6 
LVM_CMR g † 139.2 ± 24.0 137.6 ± 23.4 
LVM_ECHO indexed to height1.7 g † 70.4 ± 13.3 69.7± 12.9 
LVM_ECHO indexed to height2.7 g † 39.5 ± 7.6 39.1 ± 7.4 
LVM_CMR indexed to height1.7 g † 52.0 ± 8.3 51.4 ± 8.1 
LVM_CMR indexed to height2.7 g † 29.2 ± 4.7 28.8 ± 4.6 
SBP, systolic blood pressure; DBP, diastolic blood pressure; HTN, hypertension; OSA, obstructive sleep apnea; 
BMI, body mass index; CRF, cardiorespiratory fitness; MVPA, Moderate to Vigorous Physical Activity; LVM, left 
ventricular mass; ECHO, echocardiography; CMR, cardiac magnetic resonance. † Mean (SD) for continuous 
variables; * n (%) for categorical variables. Low CRF was defined as the lowest tertile, as measured by the recorded 
treadmill time and the estimated maximal VO2 during the last exercise test.  
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The univariate analyses revealed highly statistically significant associations between both LVM 
height indices, assessed by both ECHO and CMR, with resting SBP, HTN, high risk of OSA, 
low CRF and BMI (all p<0.01). Age, family history of cardiac problems and physical activity 
also showed a significant association with both LVM indices, when LVM was based on ECHO 
measurement (at least p<0.01).  
In all 4 models evaluated, namely with LVM assessed by ECHO or CMR and normalized with 
height to either 1.7 or 2.7, only BMI was consistently associated with LVM in a statistically 
significant fashion (p<0.001) in all multivariate models. Family history of cardiac problems and 
smoking were also statistically significant predictors in the models, where LVM was assessed by 
ECHO or by CMR, respectively, following the backward stepwise elimination process.  
Final multivariate regression models showing the associations between the statistically and 
clinically significant predictors of LVM are summarized in Table 3.3. The proportion of the 
variability in LVM normalized for height explained by our models ranged from 12.5% to 23.9%. 
In the final models, a 1-unit decrease in BMI was associated with 1 unit (kg/m1.7) reduction of 
LVM/ height 1.7 after adjustment for age, HTN, OSA risk and cardiorespiratory fitness.  
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Table 3.2: Simple Linear Regression Models of Cardiovascular Risk factors and LVM assessed 
by ECHO and CMR and normalized for height to allometric powers of 1.7 and 2.7 as Continuous 
Variable. 
  
! (SE) P ! (SE) p ! (SE) p ! (SE) p
Age, years 0.11 (0.1) 0.02* 0.10 (0.0) <0.01* 0.01 (0.1) 0.8 0.03 (0.0) 0.18
Heart Rate, bmp -0.01 (0.03) 0.78 -0.02 (0.0) 0.33 -0.02 (0.0) 0.34 -0.02 (0.0) 0.08
Resting SBP, mmHg 0.13 (0.04) <0.01* 0.08 (0.0) <0.01* 0.17 (0.0) <0.01* 0.10 (0.0) <0.01*
Resting DBP, mmHg -0.002 (0.1) 0.97 0.002 (0.0) 0.96 0.14 (0.1) <0.01* 0.08 (0.0) <0.01*
Self-reported HTN, % 5.23 (0.97) <0.01* 3.08 (0.6) <0.01* 3.44 (0.6) <0.01* 2.05 (0.4) <0.01*
High risk of OSA, % 5.64 (0.99) <0.01* 3.12 (0.6) <0.01* 3.90 (0.6) <0.01* 2.20 (0.3) <0.01*
Body Mass Index, kg/m2 0.95 (0.1) <0.01* 0.51 (0.1) <0.01* 0.86 (0.1) <0.01* 0.46 (0.0) <0.01*
Smoking, % -2.62 (1.2) 0.03* -1.3 (0.7) 0.05* -1.11 (0.77) 0.15 -0.63 (0.4) 0.15
Personal History of Heart 
Rhythm Problems, % -2.68 (1.2) 0.02* -1.48 (0.6) 0.02* -0.98 (0.75) 0.19 -0.57 (0.4) 0.19
Family History of cardiac 
problems, % 3.26 (0.8) <0.01* 2.01 (0.5) <0.01* 0.07 (0.6) 0.89 0.24 (0.5) 0.44
Low CRF, % 3.24 (0.8) <0.01* 1.94 (0.5) <0.01* 1.53 (0.6) <0.01* 0.95 (0.3) <0.01*
MVPA Physical 
Activity, min/week -0.02 (0.0) <0.01* -0.01 (0.0) <0.01* -0.002(0.0) 0.46 -0.001 (0.0) 0.28
a.      LVM normalized for height to the allometric power of 1.7.
b.     LVM normalized for height to the allometric power of 2.7
bpm: beats per minute; SBP, systolic blood pressure; DBP, diastolic blood pressure; HTN, hypertension; OSA, obstructive sleep apnea;  CRF, cardiorespiratory fitness; 
MVPA, Moderate to Vigorous Physical Activity. * statistically significant p-values.
                          Assessed by ECHO Assessed by CMR
Model 1a Model 2b Model 3a Model 4b
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Table 3.3: Multivariate Linear Regression Models of Cardiovascular Risk factors and LVM 
assessed by ECHO and CMR and normalized for height to allometric powers of 1.7 and 2.7 as 
Continuous Variable. 
  
 
 
R2
! (SE) P ! (SE) p ! (SE) p ! (SE) p
Age, years 0.04 (0.1) 0.52 0.07 (0.0) 0.07 0.02 (0.0) 0.56 0.04 (0.0) 0.05
Self-reported 
HTN 1.06 (1.2) 0.37 0.66 (0.7) 0.34 1.29 (0.7) 0.05 0.76 (0.4) 0.05
High risk of 
OSA 0.76 (1.1) 0.49 0.36 (0.6) 0.57 0.15 (0.6) 0.81 0.11 (0.4) 0.76
Body Mass 
Index, kg/m2 1.01 (0.1) <0.001* 0.55 (0.1) <0.001* 0.83 (0.1) <0.001* 0.45 (0.0) <0.001*
Low CRF -0.23 (1.0) 0.83 -0.34 (0.6) 0.57 -0.96 (0.6) 0.1 -0.70 (0.3) 0.05
a.      LVM normalized for height to the allometric power of 1.7.
b.     LVM normalized for height to the allometric power of 2.7
0.134 0.125 0.239 0.215
Assessed by ECHO Assessed by CMR
Model 1a Model 2b Model 3a Model 4b
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Discussion !
The present cross-sectional study in US firefighters using ECHO and CMR measurements found 
BMI to be the strongest and most consistent independent predictor of LVM indexed by height to 
the allometric powers of 1.7 and 2.7. In simple linear regression models, apart from BMI, the 
associations were highly statistically significant for self-reported HTN, high risk of OSA, resting 
SBP and low CRF consistently in all four models (p<0.01). In multivariate models, however, 
while following the stepwise backward elimination process, except for BMI, other conventional 
CVD risk factors such as family history of cardiac problems and smoking, were significant 
predictors of LVM. However, in all 4 models, the effect of BMI was the only consistently 
significant predictor, even after adjustment for age, HTN, high risk of OSA and low 
cardiorespiratory fitness. Therefore, our study clearly supported BMI as a major determinant of 
LVM. 
Given the epidemic level of obesity in the US fire service, it is not surprising that we found BMI 
to be the strongest predictor of LVM in this population. This is consistent with the literature, 
which finds obesity to be a risk factor for LVH and increased cardiac mass.3,24 Additionally, 
given that obesity is associated with CVD risk factor clustering38,39, it probably explains why 
other factors like blood pressure and OSA risk were weaker predictors in multivariate models 
because their association with LVM may be closely linked to their association or co-morbidity 
with obesity.18  Given our previous findings that obesity-associated SCD among younger 
firefighters was largely driven by an increased cardiac mass in SCD victims compared to 
controls,40 our results reinforce that decreasing obesity in the fire service will improve 
firefighters’ cardiovascular risk profiles, including their risk of LVH and on-duty CVD events, 
particularly SCD.    Even small reductions on BMI may produce significant beneficial effects on 
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metabolic syndrome and other CVD risk factors. 41,42 Our results suggest that a 1-unit decrease in 
BMI, will reduce the index of LVM with height to the allometric power of 1.7 by 1 unit (kg/m1.7) 
even after adjustment for age, self-reported HTN, high risk of OSA and low cardiorespiratory 
fitness. 
The results for the cohort’s baseline characteristics, especially for BMI, OSA and CRF are 
concerning. Almost 32% of the cohort screened at high risk of OSA, and more than one third had 
low CRF. We attribute these findings to the fact that almost half of the study participants were 
obese. However, after adjusting for our weighted sampling, our prevalence estimates of obesity, 
high risk of OSA and low CRF remain high and in general agreement with results from 
previously published literature on the US Fire Service. 11,38,43  
LVM measurements by ECHO were on average 49.3 grams higher than those by CMR. This 
finding is in line with current evidence, which suggests that CMR consistently yields lower 
average values compared to ECHO values for the same subjects.44,45 This suggests the urgent 
need for reference ranges adjustments for ECHO and CMR LVM estimates, respectively.  
Based on the values of R2 for our final multivariate regression models, we were able to explain 
12.5% to 13.4% of the variability of LVM indexed by height to the allometric powers of 1.7 and 
2.7 based on ECHO assessments and 21.5% to 23.9% based on CMR assessments. The models 
of the LVM when normalized with height1.7 yielded the best prediction within each imaging 
technique. Our models’ predictive ability is in line with the observed ranges for the explained 
variability of LVM. 46 We were in fact able to explain 10% more of the LVM variability with the 
CMR models as compared to ECHO ones, irrespective of the indexation technique. This is likely 
explained by the fact that CMR measurements are more standardized across techniques and 
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institutions, and less dependent on operator’s skill and experience, acoustic window adequacy 
and LVM geometric assumptions.25,47 
Our study has some modest limitations. Because of its cross-sectional design, we can only 
demonstrate associations and not causation, however, the findings are consistent with past 
studies48 and are biologically plausible. Also, because of the very small number of participating 
women firefighters in our study, only male participants were included in the present study.  
Our study also has a number of important strengths. We were able to collect comprehensive data 
on CVD risk factors from both medical examinations and a screening questionnaire. The BMI 
was measured during medical examinations, which avoided self-reporting biases towards lower 
weights and taller heights and any other random misclassification. In addition, risk of OSA was 
assessed by the widely used and validated Berlin Questionnaire, which has high sensitivity and 
specificity (86% and 77%, respectively), and demonstrates a high yield in public safety 
occupations.11,37 Moreover, we used imaging results for LVM by both ECHO and CMR, which 
boosted the clinical significance and applicability of our results across cardiology laboratories. 
Another important strength of our study is that we normalized LVM by height to two different 
allometric powers, which allowed us to perform a more holistic assessment of its potential 
predictors, considering that height is the parameter suggested as the most accurate for 
normalization purposes. Furthermore, our results were consistent among the imaging modalities 
and the indexing methods, making our findings more robust.  Finally, even though we used the 
enriched randomization sampling technique, our sample had similar anthropometric 
characteristics and CVD risk factors to those found in other epidemiologic studies of 
firefighters.38,39,49 Therefore, we believe that our results could be generalized to most male career 
firefighters.  
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In conclusion, after normalizing ECHO- and CMR-measured LVM for height, BMI was the 
strongest independent determinant of LVM among male career firefighters. Previous research in 
the fire service has found that SCD among younger firefighters was largely driven by an 
increased cardiac mass in SCD victims as compared to controls, with 2/3 of SCD victims to be 
obese. Taken together with previous research our current findings suggest that reducing obesity 
will decrease the risk of LVH and therefore, reduce on-duty CVD and SCD events in the fire 
service. Our findings also support targeted noninvasive screening for LVH with ECHO among 
obese firefighters.  
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Appendix  
Table 3.1: Distribution of Risk Factors and calculation of weights based on Inverse 
Probability Weighting. 
 
Number of Risk Factors Study sample  
N (%) 
Study base  
N (%) 
0 48 (12.6) 161 (15.20) 
1 82 (21.5) 367 (34.66) 
2 122 (32.0) 298 (28.14) 
3 
 
103 (27.0) 172 (16.24) 
4 
 
26(6.8) 61 (5.76) 
Weights per number of Risk Factors 
 Sampling Fractions Weights 
(Probability)  
0 48/161 161/48 
(3.354) 
1 82/367 367/82 
(4.475) 
2 122/298 298/122 
(2.443) 
3 103/172 172/103 
(1.670) 
4 26/61 61/26 
(2.346) 
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Summary and Conclusions 
 
The goals of this dissertation were: 1) to evaluate Left Ventricular Hypertrophy 
(LVH)/Cardiomegaly and assess how the different non-invasive screening as well as 
forensic methods and reference ranges can affect distinctions between disease states and 
normality; 2) to provide more definitive prevalence estimates of cardiac enlargement 
among US firefighters; and 3) to identify the most significant clinical predictors of Left 
Ventricular Mass (LVM) in this special occupational cohort. The findings of this work 
were extremely promising, suggesting LVM normalized by height to an allometric power 
to be the most appropriate method of assessing LVH among the US firefighters. In 
addition, considering their current CVD risk profiles, the work highlights body mass 
index (BMI) as an independent predictor that drives LVM, heart weight and LV wall 
thickness, and therefore, supports reducing obesity in the US fire service as a means to 
prevent on-duty CVD events.  
 
The results of Chapter One indicated that even though LVH/Cardiomegaly is well-
recognized as a significant clinical and epidemiologic marker of CVD, its assessment by 
measuring LVM demonstrates wide variability depending critically on the choice of the 
normalization technique, the imaging modality and the cutoff values, thus calling for an 
urgent need of standardization. In addition, Chapter One showed that echocardiography 
(ECHO) remains the most widely used diagnostic tool for the assessment of LVH, while 
it also emphasized that few direct comparisons between imaging and autopsies studies 
exist, with methods that are currently not cross-standardized; and the paucity of autopsy 
data that could further facilitate direct comparisons between the mass of the left ventricle 
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and the total cardiac mass. Overall, Chapter One highlighted the need for standardization 
of the definition of LVH/Cardiomegaly and for conducting forensic studies that will 
facilitate direct comparisons with imaging, as well as update the reference ranges for total 
heart weight in light of the contemporary population’s changes in height and weight. 
Chapter Two demonstrated a wide range of prevalence estimates of cardiac enlargement 
within and between imaging modalities according to the different criteria utilized, and 
indicated BMI as a major driver of heart weight. Therefore, the results from Chapter Two 
indicate that the choices of clinicians and researchers of imaging modalities, the 
normalization on indexing technique and the reference ranges, not only can critically 
affect the accurate determination of cardiac enlargement in the US fire service, but also 
create challenges in general clinical practice. The results from this study also suggest the 
need of outcomes’ based research that will define the best cutoffs as well as the 
standardization of autopsy report forms across protocols and jurisdictions.  
 
Chapter Three revealed BMI as the most significant and only consistent independent 
predictor of LVM normalized for height to the allometric powers of 1.7 and 2.7, by both 
ECHO and CMR measurements. In addition, a 1-unit decrease in BMI was associated 
with 1 unit reduction of the LVM indexed to height1.7, even after adjustment for CVD risk 
factors. Previous research in the fire service has found that SCD among younger 
firefighters was largely driven by an increased cardiac mass in SCD victims compared to 
controls, with 2/3 of SCD victims to be obese. Results from Chapter Three indicate BMI 
as a major driver of LVM. Thus, decreasing obesity among firefighters will lead to a 
decrease in the risk of LVH and in turn reduce on-duty CVD and SCD events in the fire 
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service.  
Taken together, the work in this dissertation suggests the urgent need of standardization 
of cardiac enlargement definitions that will further facilitate the establishment of its role 
in clinical practice and will in turn lead to an accurate determination of 
LVH/cardiomegaly in the US fire service. Given previous findings that obesity-
associated SCD among firefighters was largely driven by an increased cardiac mass in 
SCD victims compared to controls, our results reinforce that decreasing obesity in the fire 
service will improve firefighters’ cardiovascular risk profiles, including their risk of LVH 
and significantly reduce on-duty CVD events, particularly SCD. Moreover, results from 
chapter Three support BMI as a major driver of LVM, while results from Chapter  Two 
suggest that BMI is driving heart weight and LV wall thickness. Chapter One suggests 
that LVM accounts for a greater proportion of total heart weight in diseased hearts 
compared to controls, and therefore, collectively our work suggests targeted noninvasive 
screening for LVH with ECHO among obese firefighters. 
 
We believe that future studies are needed to validate the assessment of 
LVH/Cardiomegaly based on the LVM normalized by height to the allometric power of 
1.7, and to identify the reference values that would be most appropriate for US 
firefighters considering the special CVD risk profiles of this occupational cohort. 
Moreover, future forensic studies are needed to directly compare total cardiac mass to left 
ventricular mas, in order to establish a firm relationship between the two. Finally, we 
suggest that future prospective studies of CVD events are needed to show that BMI is the 
most significant and useful prognostic indicator of LVM, and therefore, likely CVD 
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susceptibility within the US fire service.  We hope that this work has contributed valuable 
information to the scientific community and will lead the way forward to improved health 
and employment outcomes among firefighters in the US. 
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